The survival module was used to look at the clinical significance of tumor immune subsets (CD8+ T cell, CD4+ T cell, macrophage, B cell, neutrophil, and dendritic cell) in BRCA-Her2, KIRC, KIRP, LUAD, THCA, and THYM. The gene discussed is CD4; the disease is neoplasm.